ATAGI replace on boosters following COVID-19 assembly on 11 November 2022
15 November 2022
ATAGI has reviewed its booster dose recommendation (November 2022) for COVID-19 vaccines within the context of accelerating case numbers in Australia and the emergence of the XBB and BQ.1 Omicron subvariants.
ATAGI needs to supply the next updates:
- ATAGI has made no new suggestions presently, together with no adjustments to the variety of COVID-19 vaccine booster doses advisable.
- ATAGI emphasises the significance of remaining updated with advisable doses of COVID- 19 vaccines, particularly for individuals aged 65 years and older and people at greater threat of extreme COVID-19:
- As of 9 November 2022, 5.5 million eligible individuals residing in Australia (27.8% of the eligible inhabitants) had not acquired a primary booster dose, and three.2 million individuals aged 50 years and older (42.7%) had not acquired a second booster dose.1
- Adults aged 30 to 49 years can contemplate a second booster dose, and 4.4 million individuals aged 30-49 years (84%) haven’t but acquired one.1
- Underneath-vaccinated persons are at an elevated threat of extreme sickness and loss of life. Staying updated with vaccine suggestions is a crucial approach an individual can defend themselves within the present context of elevated COVID-19 circumstances.
- ATAGI continues to suggest that every one individuals defer COVID-19 vaccination for 3 months after a confirmed SARS-CoV-2 an infection. The subsequent scheduled dose ought to then be given as quickly as potential.
- Eligible people can obtain both a bivalent or unique COVID-19 vaccine, whichever is on the market to them. Each bivalent and unique vaccines lead to an enchancment within the immune response in opposition to Omicron subvariants.
- The rise in COVID-19 circumstances in Australia commenced a number of weeks in the past. It’s unclear when the wave will peak or finish. Any discount in group transmission in Australia from a further booster dose in people who find themselves already updated is more likely to be minimal.
- A current wave of the XBB subvariant in Singapore was of brief length and of small dimension. Extreme illness and loss of life have been uncommon in individuals who had acquired no less than two doses of a COVID-19 vaccine.2
- ATAGI notes the next measures advisable by well being officers through the present improve in COVID-19 circumstances:
- persons are suggested to make use of masks in indoor public locations and crowded settings 3
- individuals who check optimistic for COVID-19 or really feel unwell ought to keep at dwelling till signs resolve 3
- Individuals eligible for oral COVID-19 remedies, ought to converse with their physician earlier than they get sick to see if COVID-19 antivirals are proper for them.4
- ATAGI continues to actively assessment the function of booster doses within the COVID-19 vaccination program. New booster dose suggestions are anticipated in early 2023 in preparation for winter. Future suggestions will intention to supply ongoing clear steering throughout all teams together with time since final dose and definitions of eligibility.
- Division of Well being and Aged Care, Australian authorities. COVID-19 vaccine roll-out, 10 November 2022. Accessible from: https://www.well being.gov.au/websites/default/information/paperwork/2022/11/covid-19-vaccine- rollout-update-10-november-2022.pdf (Accessed 13 November 2022)
- Ministry of Well being, Singapore. Replace on COVID-19 scenario and measures to guard healthcare capability. 2022. Accessible from: https://www.moh.gov.sg/news- highlights/particulars/update-on-covid-19-situation-and-measures-to-protect-healthcare- capability (Accessed 13 November 2022)
- Division of Well being and Aged Care, Australian authorities. New COVID-19 variant results in improve in circumstances. 2022. Accessible from: https://www.well being.gov.au/information/new-covid-19- variant-leads-to-increase-in-cases (Accessed 13 November 2022)
- Division of Well being and Aged Care, Australian authorities. Oral remedies for COVID-19. 2022. Accessible from: https://www.well being.gov.au/health-alerts/covid-19/remedies/oral (Accessed 13 November 2022)